Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medacta Group SA Revises Revenue Guidance for the Full Year 2021

07/20/2021 | 01:00am EDT

Medacta Group SA revises revenue guidance for the full year 2021. The positive first semester performance and the business outlook in the remainder of the year allow the company to revise upward revenue target for 2021 within a range of EUR 355 million to EUR 375 million at constant currency, compared to the previous range of EUR 333 million to EUR 348 million, subject to any unforeseen events, specifically from the Covid-19 pandemic.


© S&P Capital IQ 2021
All news about MEDACTA GROUP SA
09/16MEDACTA : celebrates the milestone of 10,000 Medacta Shoulder System implanted worldwide!
PU
09/14MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral Recommendat..
MT
09/10MEDACTA : Swiss Medical Device Maker Medacta's H1 Profit Climbs as All Business Areas Expa..
MT
09/10MEDACTA : reports strong profitability with 31.9% adjusted EBITDA margin in the first seme..
PU
09/10MEDACTA : Press Release – 2021 Half-Year Results
PU
09/10MEDACTA : 2021 Half-Year Report
PU
09/10MEDACTA : 2021 Half-Year Presentation
PU
09/10Medacta reports strong profitability -2-
DJ
09/10Medacta reports strong profitability with 31.9% adjusted EBITDA margin in the first sem..
DJ
09/10Medacta Group SA Confirms Revenue Guidance for the Year 2021
CI
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2021 348 M 406 M 406 M
Net income 2021 56,0 M 65,5 M 65,5 M
Net Debt 2021 83,5 M 97,6 M 97,6 M
P/E ratio 2021 54,5x
Yield 2021 0,49%
Capitalization 3 052 M 3 309 M 3 568 M
EV / Sales 2021 9,02x
EV / Sales 2022 7,83x
Nbr of Employees 1 246
Free-Float 30,5%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 152,60 €
Average target price 107,02 €
Spread / Average Target -29,9%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA73.52%3 290
ABBOTT LABORATORIES14.28%221 833
MEDTRONIC PLC9.13%172 048
BECTON, DICKINSON AND COMPANY3.51%74 382
HOYA CORPORATION28.03%62 177
SARTORIUS STEDIM BIOTECH84.00%57 875